HealthTree

Playlist: Precursor Conditions (2020)

BETA - How is smoldering multiple myeloma (SMM) stratified?

Maintaining and Communicating your Sexual Wellness

Feb 02, 2022

07:00PM - 08:00PM EST

Playlist: Financial Advice for Myeloma Patients and Their Families

(Guest Lecture): Budgeting Workshop Paying for the Costs of Cancer

A New CAR T Target in Multiple Myeloma: GPRC5D

A New CAR T Target in Multiple Myeloma: GPRC5D image

Playlist: Nutrition and Diet as a Biologically-Based Therapy

(Guest Lecture): Studying The Relationship between Myeloma Progression and Diet

Navigating Neuropathy through Nutrition

Jan 26, 2022

01:00PM - 02:00PM EST

Studying The Relationship between Myeloma Progression and Diet

Jan 25, 2022

07:00PM - 08:15PM EST

Finding Free COVID Test For Medicare Beneficiaries

Finding Free COVID Test For Medicare Beneficiaries image

Post-ASH January 22, 2022 Myeloma Round Table

Jan 22, 2022

12:00PM - 01:30PM EST

Playlist: Know Your Myeloma Therapy

(Guest Lecture ): Know Your Myeloma Therapy: Carfilzomib (Kyprolis) with Dr. Harsh Parmar

Motixafortide: A New Drug to Mobilize Stem Cells Prior to Stem Cell Transplant

Motixafortide: A New Drug to Mobilize Stem Cells Prior to Stem Cell Transplant image

Know Your Myeloma Therapy: Carfilzomib (Kyprolis) with Dr. Harsh Parmar

Jan 20, 2022

01:00PM - 02:00PM EST

Full Show: Tasquinimod As a New Myeloma Therapy with Dan Vogl, MD and Yulia Nefedova, MD, PhD

Full Show: Tasquinimod As a New Myeloma Therapy with Dan Vogl, MD and Yulia Nefedova, MD, PhD image

Full Show: Exploring Innovative Immunotherapy with Drs. Jim Allison and Pam Sharma

Full Show: Exploring Innovative Immunotherapy with Drs. Jim Allison and Pam Sharma image

Pulling Together Costs for Your 2021 Tax Filing

Pulling Together Costs for Your 2021 Tax Filing image

The Coach Program- Hear It From The Coaches Themselves

Jan 12, 2022

01:00PM - 02:00PM EST

Engineered Toxin Bodies Targeting CD38 in Myeloma with Shaji Kumar, MD, Mayo Clinic

A new treatment called Engineered Toxin Bodies (ETBs) with a stronger mechanism of action is being developed by Molecular Templates.

Engineered Toxin Bodies Targeting CD38 in Myeloma with Shaji Kumar, MD, Mayo Clinic image

Early Indicators for Depth of Response Rates in Myeloma Patients Treated with BCMA CAR T Cells

Early Indicators for Depth of Response Rates in Myeloma Patients Treated with BCMA CAR T Cells image

The 2026 Multiple Myeloma Landscape with Robert Orlowski, MD, PhD, MD Anderson Cancer Center

Learn about what's here and what's coming in 2026 in multiple myeloma care with myeloma expert Robert Orlowski, MD, PhD

The 2026 Multiple Myeloma Landscape with Robert Orlowski, MD, PhD, MD Anderson Cancer Center image

A Look into the 2025 Multiple Myeloma Landscape with Robert Orlowski, MD, PhD, MD Anderson Cancer Center

Learn about what's here and what's coming in 2025 in multiple myeloma care with myeloma expert Robert Orlowski, MD, PhD

A Look into the 2025 Multiple Myeloma Landscape with Robert Orlowski, MD, PhD, MD Anderson Cancer Center image

Minimal Residual Disease (MRD) Testing with Dr. Rafael Fonseca

Join Rafael Fonseca, MD, Mayo Clinic to learn when MRD testing should be done and how the results should be used in myeloma care.

Minimal Residual Disease (MRD) Testing with Dr. Rafael Fonseca image

The 2024 Multiple Myeloma Landscape with Robert Orlowski, MD, PhD, MD Anderson Cancer Center

Learn about what's here and what's coming in 2024 in multiple myeloma care with myeloma expert Robert Orlowski, MD, PhD

The 2024 Multiple Myeloma Landscape with Robert Orlowski, MD, PhD, MD Anderson Cancer Center image

The Future of Bispecific Antibodies with Dr. Philippe Moreau

Dr. Moreau will provide a review of approved and in-development bispecific antibodies, side effect management and more.

The Future of Bispecific Antibodies with Dr. Philippe Moreau image